- More institutions held and increased positions in the US spot BTC ETFs in Q2.
- Morgan Stanley and Goldman Sachs are now the top five holders of BlackRock’s IBIT.
Institutional investors’ appetite for US spot Bitcoin [BTC] ETFs hasn’t waned, despite the digital asset’s drawdowns and volatility in Q2.
According to Bitwise’s CIO Matt Hougan, the accumulation trend witnessed after the products debuted in Q1 remained ‘intact’ in Q2, with a 30% increase in holders.
“I count 1,924 holders ETF pairs across all 10 ETFs, up from 1,479 in Q1. That’s a 30% increase; not bad considering prices fell in Q2…Institutional investors continued to adopt bitcoin ETFs in Q2. The trend is intact.”
Institutions held BTC ETFs despite Q2 dump
Hougan also noted that 66% of professional investors who bought the products in Q1 either held or increased their holdings in Q2.
“Among Q1 filers, 44% increased their position in bitcoin ETFs in Q2, 22% held steady, 21% decreased their position, and 13% exited. That’s a pretty good result, on par with other ETFs.”
This went against the perceived notion that they would capitulate and dump upon any slightest volatility or plunge. For context, BTC plummeted 12% in Q2, dropping from $72K to $56K before closing above $60K.
As a result, the Bitwise exec called them ‘diamond’ hands for holding steady despite the headwinds.
Recent 13F filings also revealed that Goldman Sachs and Morgan Stanley were among the top five holders of BlockRock’s iShares Bitcoin Trust (IBIT).
As of the 30th of June, Goldman Sachs held $238.6M of IBIT, while Morgan Stanley held $187M.
It’s worth noting that Morgan Stanley and Goldman Sachs are part of the major wirehouses (large dealers), which were expected to drive the second wave of adoption for BTC ETFs from Q3 onwards.
Morgan Stanley has already begun recommending BTC ETFs to specific clients, which could drive further adoption.
The trend could also rally institutional investors’ contribution to the BTC ETF’s AUM (assets under management).
In Q1, institutions accounted for $3 — $5 billion (7%- 10%) of the BTC ETF’s total AUM, which stood at $50B then. At the time of writing, the total BTC ETF’s AUM was $53.6B.
Source: Soso Value
Interestingly, institutional investors’ accumulation of BTC ETF has picked momentum in Q3, too.
According to Glassnode data, major ETF wallets have ramped up accumulation, a trend witnessed in March that tipped BTC to hit an ATH of $73K.
“Recently, this trend (supply distribution) has shown signs of reversing, especially among the largest wallets, often linked to ETFs, which are now returning to accumulation.”
Source: Glassnode
- More institutions held and increased positions in the US spot BTC ETFs in Q2.
- Morgan Stanley and Goldman Sachs are now the top five holders of BlackRock’s IBIT.
Institutional investors’ appetite for US spot Bitcoin [BTC] ETFs hasn’t waned, despite the digital asset’s drawdowns and volatility in Q2.
According to Bitwise’s CIO Matt Hougan, the accumulation trend witnessed after the products debuted in Q1 remained ‘intact’ in Q2, with a 30% increase in holders.
“I count 1,924 holders ETF pairs across all 10 ETFs, up from 1,479 in Q1. That’s a 30% increase; not bad considering prices fell in Q2…Institutional investors continued to adopt bitcoin ETFs in Q2. The trend is intact.”
Institutions held BTC ETFs despite Q2 dump
Hougan also noted that 66% of professional investors who bought the products in Q1 either held or increased their holdings in Q2.
“Among Q1 filers, 44% increased their position in bitcoin ETFs in Q2, 22% held steady, 21% decreased their position, and 13% exited. That’s a pretty good result, on par with other ETFs.”
This went against the perceived notion that they would capitulate and dump upon any slightest volatility or plunge. For context, BTC plummeted 12% in Q2, dropping from $72K to $56K before closing above $60K.
As a result, the Bitwise exec called them ‘diamond’ hands for holding steady despite the headwinds.
Recent 13F filings also revealed that Goldman Sachs and Morgan Stanley were among the top five holders of BlockRock’s iShares Bitcoin Trust (IBIT).
As of the 30th of June, Goldman Sachs held $238.6M of IBIT, while Morgan Stanley held $187M.
It’s worth noting that Morgan Stanley and Goldman Sachs are part of the major wirehouses (large dealers), which were expected to drive the second wave of adoption for BTC ETFs from Q3 onwards.
Morgan Stanley has already begun recommending BTC ETFs to specific clients, which could drive further adoption.
The trend could also rally institutional investors’ contribution to the BTC ETF’s AUM (assets under management).
In Q1, institutions accounted for $3 — $5 billion (7%- 10%) of the BTC ETF’s total AUM, which stood at $50B then. At the time of writing, the total BTC ETF’s AUM was $53.6B.
Source: Soso Value
Interestingly, institutional investors’ accumulation of BTC ETF has picked momentum in Q3, too.
According to Glassnode data, major ETF wallets have ramped up accumulation, a trend witnessed in March that tipped BTC to hit an ATH of $73K.
“Recently, this trend (supply distribution) has shown signs of reversing, especially among the largest wallets, often linked to ETFs, which are now returning to accumulation.”
Source: Glassnode
Устали от бесконечной рекламы на сайтах для просмотра фильмов? https://kinogo-films.biz/ — это ваш спаситель! Этот сайт предлагает зрителям из России и стран СНГ смотреть фильмы и сериалы в отличном HD 1080 качестве без каких-либо рекламных пауз и регистрации. В каталоге представлены все жанры, от классики до новинок 2024 года, такие как «Джентльмены» и «Тенет».
На сайте вы найдете всё, что нужно для идеального киновечера: огромное количество фильмов, качественные переводы и удобный интерфейс. Хватит тратить время на рекламу — наслаждайтесь кино на https://kinogo-films.biz/!
can i buy clomid where can i get cheap clomid can i buy generic clomiphene tablets clomid medication can you get generic clomiphene for sale buying generic clomiphene pill where to get cheap clomiphene
This is the kind of content I have reading.
The thoroughness in this piece is noteworthy.
zithromax for sale – buy floxin generic buy metronidazole 400mg sale
buy generic rybelsus 14 mg – buy periactin no prescription cyproheptadine 4mg tablet
motilium online – cyclobenzaprine over the counter purchase cyclobenzaprine sale
order augmentin 1000mg pills – atbioinfo.com ampicillin for sale
buy nexium 40mg for sale – anexa mate nexium 40mg drug
buy medex for sale – https://coumamide.com/ where can i buy losartan
order generic mobic 15mg – https://moboxsin.com/ meloxicam online buy
deltasone 10mg tablet – https://apreplson.com/ buy prednisone cheap
ed pills – where can i buy ed pills best pills for ed
buy amoxicillin generic – comba moxi amoxil pills
diflucan 100mg sale – https://gpdifluca.com/ generic diflucan 100mg
escitalopram us – https://escitapro.com/# order lexapro pills
cenforce brand – https://cenforcers.com/# order cenforce 50mg
tadalafil dose for erectile dysfunction – https://ciltadgn.com/# buy cialis no prescription australia
where to buy cialis online for cheap – on this site side effects of cialis
where can i buy ranitidine – zantac 300mg drug buy zantac online cheap
real viagra 100mg – https://strongvpls.com/ sildenafil 100
This is the big-hearted of criticism I truly appreciate. https://buyfastonl.com/furosemide.html
This is the kind of literature I truly appreciate. https://ursxdol.com/provigil-gn-pill-cnt/
Greetings! Extremely productive par‘nesis within this article! It’s the scarcely changes which choice obtain the largest changes. Thanks a a quantity for sharing! https://prohnrg.com/product/orlistat-pills-di/